BlackRock’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,750,000
Closed -$28.9M 5384
2020
Q4
$28.9M Buy
+2,750,000
New +$28.7M ﹤0.01% 2812

Other funds holding MTACU

BlackRock's MTACU Position: Q1 2021 in Review

BlackRock sold out of MedTech Acquisition Corporation Unit (MTACU) in Q1 2021, closing a stake of 2,750,000 shares — an estimated $28.9M sold.

BlackRock first reported a position in MTACU in Q4 2020 and held it in 1 quarter. The position peaked at $28.9M in Q4 2020. 31 funds tracked by Wall St. Rank hold MTACU as of Q1 2021.

  • BlackRock reported no remaining MedTech Acquisition Corporation Unit position as of Q1 2021 after selling out during the quarter.
  • BlackRock sold 2,750,000 MedTech Acquisition Corporation Unit shares in Q1 2021, an estimated $28.9M.
  • BlackRock first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 1 quarter.
  • BlackRock's MedTech Acquisition Corporation Unit position peaked at $28.9M in Q4 2020.
  • 31 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q1 2021.

Based on BlackRock's 13F filing for Q1 2021, filed 7 May 2021.